_version_ 1785090461905453056
author Tembhare, Prashant
Raj, Simpy
Ghogale, Sitaram
Deshpande, Nilesh
Girase, Karishma
Chatterjee, Gaurav
Rajpal, Sweta
Patkar, Nikhil
Narula, Gaurav
Bagal, Bhausaheb
Jain, Hasmukh
Sengar, Manju
Banavali, Shripad
Shetty, Dhanlaxmi
Dhamne, Chetan
Khanka, Twinkle
Varghese, Steffi
Jasdanwala, Shaista
Khattry, Navin
G Subramanian, Papagudi
Gujral, Sumeet
author_facet Tembhare, Prashant
Raj, Simpy
Ghogale, Sitaram
Deshpande, Nilesh
Girase, Karishma
Chatterjee, Gaurav
Rajpal, Sweta
Patkar, Nikhil
Narula, Gaurav
Bagal, Bhausaheb
Jain, Hasmukh
Sengar, Manju
Banavali, Shripad
Shetty, Dhanlaxmi
Dhamne, Chetan
Khanka, Twinkle
Varghese, Steffi
Jasdanwala, Shaista
Khattry, Navin
G Subramanian, Papagudi
Gujral, Sumeet
author_sort Tembhare, Prashant
collection PubMed
description
format Online
Article
Text
id pubmed-10428408
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284082023-08-17 P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL) Tembhare, Prashant Raj, Simpy Ghogale, Sitaram Deshpande, Nilesh Girase, Karishma Chatterjee, Gaurav Rajpal, Sweta Patkar, Nikhil Narula, Gaurav Bagal, Bhausaheb Jain, Hasmukh Sengar, Manju Banavali, Shripad Shetty, Dhanlaxmi Dhamne, Chetan Khanka, Twinkle Varghese, Steffi Jasdanwala, Shaista Khattry, Navin G Subramanian, Papagudi Gujral, Sumeet Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428408/ http://dx.doi.org/10.1097/01.HS9.0000968352.94316.c1 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Tembhare, Prashant
Raj, Simpy
Ghogale, Sitaram
Deshpande, Nilesh
Girase, Karishma
Chatterjee, Gaurav
Rajpal, Sweta
Patkar, Nikhil
Narula, Gaurav
Bagal, Bhausaheb
Jain, Hasmukh
Sengar, Manju
Banavali, Shripad
Shetty, Dhanlaxmi
Dhamne, Chetan
Khanka, Twinkle
Varghese, Steffi
Jasdanwala, Shaista
Khattry, Navin
G Subramanian, Papagudi
Gujral, Sumeet
P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
title P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
title_full P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
title_fullStr P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
title_full_unstemmed P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
title_short P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
title_sort p360: measurable/minimal residual disease (mrd) status is the most relevant indicator of clinical outcome in mixed phenotypic acute leukemias (mpal)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428408/
http://dx.doi.org/10.1097/01.HS9.0000968352.94316.c1
work_keys_str_mv AT tembhareprashant p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT rajsimpy p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT ghogalesitaram p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT deshpandenilesh p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT girasekarishma p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT chatterjeegaurav p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT rajpalsweta p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT patkarnikhil p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT narulagaurav p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT bagalbhausaheb p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT jainhasmukh p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT sengarmanju p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT banavalishripad p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT shettydhanlaxmi p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT dhamnechetan p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT khankatwinkle p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT varghesesteffi p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT jasdanwalashaista p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT khattrynavin p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT gsubramanianpapagudi p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal
AT gujralsumeet p360measurableminimalresidualdiseasemrdstatusisthemostrelevantindicatorofclinicaloutcomeinmixedphenotypicacuteleukemiasmpal